Sarah Maxfield
Sarah Maxfield is an Alliance Manager at AstraZeneca Pharmaceuticals, and recently led a number of deals and strategic alliances with academic groups, including a compound sharing deal with the MRC.
She previously worked as an IP Evaluation Officer at University of Newcastle, and as a Research Scientist at ProCure Therapeutics.
Sarah has a PhD Biochemistry from the University of Leeds and a BSc Biology / Biochemistry from the University of York.